Zinc Transporter 8 Antibodies Complement GAD and IA-2 Antibodies in the Identification and Characterization of Adult-Onset Autoimmune Diabetes
Open Access
- 6 October 2009
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 33 (1), 104-108
- https://doi.org/10.2337/dc08-2305
Abstract
OBJECTIVE Zinc transporter 8 (ZnT8) is an islet β-cell secretory granule membrane protein recently identified as an autoantibody antigen in type 1 diabetes. The aim of this study was to determine the prevalence and role of antibodies to ZnT8 (ZnT8As) in adult-onset diabetes. RESEARCH DESIGN AND METHODS ZnT8As were measured by a radioimmunoprecipitation assay using recombinant ZnT8 COOH-terminal or NH2-terminal proteins in 193 patients with adult-onset autoimmune diabetes having antibodies to either GAD (GADAs) or IA-2 (IA-2As) and in 1,056 antibody-negative patients with type 2 diabetes from the Non Insulin Requiring Autoimmune Diabetes (NIRAD) study. RESULTS ZnT8As-COOH were detected in 18.6% patients with autoimmune diabetes and 1.4% with type 2 diabetes. ZnT8As-NH2 were rare. ZnT8As were associated with younger age and a high GADA titer. The use of GADAs, IA-2As, and ZnT8As in combination allowed a stratification of clinical phenotype, with younger age of onset of diabetes and characteristics of more severe insulin deficiency (higher fasting glucose and A1C, lower BMI, total cholesterol, and triglycerides) in patients with all three markers, with progressive attenuation in patients with two, one, and no antibodies (all Ptrend < 0.001). Autoantibody titers, association with high-risk HLA genotypes, and prevalence of thyroid peroxidase antibodies followed the same trend (all P < 0.001). CONCLUSIONS ZnT8As are detectable in a proportion of patients with adult-onset autoimmune diabetes and seem to be a valuable marker to differentiate clinical phenotypes.Keywords
This publication has 16 references indexed in Scilit:
- The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial resultsPediatric Diabetes, 2009
- The Protein Tyrosine Phosphatase Nonreceptor 22 (PTPN22) Is Associated With High GAD Antibody Titer in Latent Autoimmune Diabetes in AdultsDiabetes Care, 2008
- High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune DiabetesDiabetes Care, 2007
- The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetesProceedings of the National Academy of Sciences of the United States of America, 2007
- High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune DiabetesDiabetes Care, 2007
- Screening Strategies for the Identification of Multiple Antibody-Positive Relatives of Individuals with Type 1 DiabetesJournal of Clinical Endocrinology & Metabolism, 2003
- UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetesThe Lancet, 1997
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Concentration of Insulin Autoantibodies at Onset of Type I Diabetes: Inverse Log-Linear Correlation With AgeDiabetes Care, 1988
- Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin TreatmentScience, 1983